Heng Du

6PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2024
Plasmacytoid Dendritic Cells: Bring a Glimmer of Hope for Patients with Lymphangioleiomyomatosis.

Heng Du, Heng-Jia Liu

|Mar 01, 2024
Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update.

Andrew J Wagner, Vinod Ravi, Richard F Riedel

|Jan 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.

Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca

|Oct 12, 2021
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors.

Andrew J Wagner, Vinod Ravi, Richard F Riedel

|Sep 21, 2021
Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.

Ji Wang, Harilaos Filippakis, Thomas Hougard

Pageof 1